Rule CG-RFA-005
Disease claims: what rule CG-RFA-005 checks
Rule CG-RFA-005 is one of the checker's disease claims rules. It cites 21 CFR 101.93(g). The reason, source and safer wording are below.
CG-RFA-005 · Blocks approval · Citation checked against stored text
Linking CBD, kratom or other cannabinoid products to cancer, seizures, anxiety, pain, withdrawal or other conditions is an unapproved drug claim; the FDA has sent many warning letters on this.
Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Health Products Compliance Guidance
Safer wording: Remove the condition and health-benefit claims from CBD and kratom copy.
21 CFR 101.93(g) · Needs counsel review
Next step
Check your copy against this rule
Run the checker and every flag cites its rule and source.